May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...
VirTra Reports Earnings for the First Quarter of 2017
May 15, 2017 12:32 pm UTC| Business
TEMPE, Ariz., May 15, 2017 -- VirTra, Inc.(OTCQX:VTSI), (the “Company”), a leading provider of judgmental use of force simulatorsand firearms training simulators, today announced its financial results for the first...
VirTra Reports Earnings for the First Quarter of 2017
May 15, 2017 12:32 pm UTC| Business
TEMPE, Ariz., May 15, 2017 -- VirTra, Inc.(OTCQX:VTSI), (the “Company”), a leading provider of judgmental use of force simulatorsand firearms training simulators, today announced its financial results for the first...
VirTra Reports Earnings for the First Quarter of 2017
May 15, 2017 12:32 pm UTC| Business
TEMPE, Ariz., May 15, 2017 -- VirTra, Inc.(OTCQX:VTSI), (the “Company”), a leading provider of judgmental use of force simulatorsand firearms training simulators, today announced its financial results for the first...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 12:32 pm UTC| Business
WESTMINSTER, Colo., May 15, 2017 -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 12:32 pm UTC| Business
WESTMINSTER, Colo., May 15, 2017 -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight